Institut de Biologie Structurale (IBS), Université Grenoble Alpes, CNRS, CEA, 71 Avenue des Martyrs, 38042, Grenoble, France.
Unité de Virologie, Institut de Recherche Biomédicale des Armées, BP 73, 91223, Brétigny-sur-Orge Cedex, France.
Nat Commun. 2017 Nov 13;8(1):1455. doi: 10.1038/s41467-017-01542-z.
Vaccinia virus (VACV), the prototype member of the Poxviridae, replicates in the cytoplasm of an infected cell. The catalytic subunit of the DNA polymerase E9 binds the heterodimeric processivity factor A20/D4 to form the functional polymerase holoenzyme. Here we present the crystal structure of full-length E9 at 2.7 Å resolution that permits identification of important poxvirus-specific structural insertions. One insertion in the palm domain interacts with C-terminal residues of A20 and thus serves as the processivity factor-binding site. This is in strong contrast to all other family B polymerases that bind their co-factors at the C terminus of the thumb domain. The VACV E9 structure also permits rationalization of polymerase inhibitor resistance mutations when compared with the closely related eukaryotic polymerase delta-DNA complex.
痘病毒(VACV)是痘病毒科的原型成员,在感染细胞的细胞质中复制。DNA 聚合酶 E9 的催化亚基与异二聚体延伸因子 A20/D4 结合形成功能完整的聚合酶全酶。本文呈现了分辨率为 2.7 Å 的全长 E9 的晶体结构,可识别重要的痘病毒特异性结构插入。手掌结构域中的一个插入片段与 A20 的 C 末端残基相互作用,因此是延伸因子结合位点。这与其他所有家族 B 聚合酶形成鲜明对比,后者在拇指结构域的 C 末端结合其辅助因子。与密切相关的真核聚合酶 delta-DNA 复合物相比,VACV E9 结构还可以解释聚合酶抑制剂耐药突变。